Tags Posts tagged with "Jeff Vacirca"

Jeff Vacirca

Over $1 million was raised through the remarkable generosity of attendees at the 3rd Annual Raising Hope Gala, hosted by the New York Cancer Foundation (NYCF), a 501(c)(3) organization dedicated to providing financial assistance to cancer patients in the Greater New York Metro Area. The event, themed “Hope Grows Here,” continued the tradition of supporting the Foundation’s mission to alleviate the financial burdens experienced by patients undergoing cancer treatment. 

“It was a remarkable evening surrounded by fellow advocates, friends, and partners, reminding us of the impact we can create when we stand united,” said Jeff Vacirca, MD, CEO of New York Cancer & Blood Specialists and Chairman of the Board, NYCF. “Since its inception, the Foundation has touched the lives of tens of thousands of patients.” 

The funds raised will be instrumental in providing financial assistance to cancer patients throughout the Greater New York Metro Area, helping to ease the financial stressors associated with their day-to-day living expenses, including rent/mortgage payments and utility bills. 

“It is through the generosity of our attendees—really all of our donors throughout the year—that we are able to help so many patients during their most difficult times. Hope truly grows here!” said Tina Toulon, Executive Director of NYCF. 

The Raising Hope Gala also featured several notable guests and moments, including world-renowned photographer Nigel Barker and Art Bodega magazine. A breast cancer survivor and a grant recipient from NYCF shared her inspiring journey, reminding attendees of the profound impact of their support. 

A special honoree of the evening was Mr. Ted Okon, Executive Director of the Community Oncology Alliance, whose tireless efforts and advocacy for cancer patients have made a significant difference in the field of oncology. 

The NYCF would like to express its deep appreciation for the support of the 2023 sponsors, whose generosity played a pivotal role in the success of the gala: 

American Regent 

Beigene 

Cairo Diagnostics 

Daiichi Sankyo 

Eagle Pharmaceuticals 

Eisai 

Gilead

GSK 

Novartis 

One Oncology 

Patient Point 

Sanofi 

Spectrum Pharmaceuticals 

Vanguard Pharma 

About the New York Cancer Foundation (NYCF) 

The New York Cancer Foundation is a 501 (c)(3) organization that offers financial assistance to patients in the Greater New York Metro Area with cancer diagnoses. Our foundation strives to relieve qualified patients of financial stressors of day-to-day living expenses, including rent/mortgage payments and utility payments.

Dr. Neal Murphy. Photo courtesy of NYCBS

New York Cancer & Blood Specialists (NYCBS) recently announced the addition of oncologist-hematologist Neal Murphy, MD. 

Dr. Murphy will practice at 750 Old Country Rd, Riverhead,640 County Rd, Southampton, and 49 Route 347, Port Jefferson Station.

“Dr. Murphy’s dedication to research and patient care is truly commendable,” said Jeff Vacirca, MD, CEO of NYCBS. “We are proud to have Dr. Murphy join our practice and look forward to the positive impact he will make in the lives of our patients.”

Dr. Murphy has dedicated his time to research focusing on kidney and bladder cancer. Dr. Murphy completed two translational research studies, including “Prognostic molecular signatures for metastatic potential in clinically low-risk stage I and II clear cell renal cell carcinomas,” which was published in Frontiers in Oncology, and “Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle-invasive bladder cancer” which was published in Oncotarget. 

Dr. Murphy has several other peer-reviewed publications and has presented his work at national conferences. He remains passionate about optimizing treatments in hematology/oncology and treats a broad spectrum of diseases with a focus on genitourinary, lung, head and neck, colorectal and skin malignancies, as well as multiple myeloma and lymphoma.

“I strive to get to know all my patients, build trust and provide the kind of care that one of my family members or I would want to receive,” Dr. Murphy said. 

“When communicating with patients, I am honest and open, explaining all treatment options and agreeing on the best, personalized treatment plan together. It is rewarding to be able to alleviate a patient’s anxiety and fear about their diagnosis and to be able to provide hope because there are so many effective treatments NYCBS and I can offer to help patients.”

To make an appointment with Dr. Murphy, please call 631-751-3000. For more information, visit nycancer.com.

New York Cancer & Blood Specialists (NYCBS) has announced the appointments of Paul Kazemier to Senior Vice President of Patient Communications and Kathryn Paliotta to Vice President of Patient Communications.

“Paul’s appointment as Senior Vice President of Patient Communications is a testament to his exceptional leadership in overseeing a team of over 275+ employees and his continued dedication to enhancing patient communication,” said Jeff Vacirca, MD, CEO of NYCBS. “His forward-thinking approach and adaptability to change will enable the organization to achieve improved outcomes for healthcare providers and patients, demonstrating our commitment to delivering exceptional value to our partners, patients, and the community.”

“Kathryn’s dedication and leadership have been invaluable to our organization, and we are thrilled to recognize her contributions with this well-deserved promotion,” said Vacirca. “Her extensive clinical background, coupled with her ability to effectively manage our patient communication departments, has allowed us to provide even better care and support to our patients. We look forward to seeing her continued success in her new role as Vice President of Patient Communications.”

“I am incredibly grateful for this promotion and the opportunity to continue to lead and grow my departments. It means the world to me,” said Kazemier. “My goal is to not only ensure the highest level of patient satisfaction and experience but also to foster an environment where employees can grow within the company and achieve their own success.”

“I am immensely grateful to have found my niche,” Paliotta said. “Working for an organization as diverse as ours has afforded me the privilege to care for patients across various specialties. I have also had the pleasure to learn from an inspiring group of mentors and look forward to growing my career at NYCBS.”

For more information, visit nycancer.com.

Anthony Peterson

New York Cancer & Blood Specialists (NYCBS), has announced the appointment of Anthony Peterson to Chief of Business Development.

“Anthony’s promotion to Chief is a significant step in our ongoing efforts to create an organization that provides exceptional value to our partners, patients, and the community,” said Jeff Vacirca, MD, CEO of NYCBS. “With his demonstrated ability to embrace change and think creatively, we are confident that he will be instrumental in leading the organization towards improved outcomes, benefiting healthcare providers and patients alike. I am excited to see the next stage of business growth for NYCBS under his leadership.”

Peterson previously served as Vice President in the development, management, and driving of strategic partnerships and key business opportunities. As Chief, he will continue to work closely under the direction of OneOncology’s Chief Development Officer, Jimmy Harper, and Vice President of Development, Henry Varnell, to cultivate and strengthen relationships and growth at a national level.

“I am thrilled and grateful to have been promoted to the role of Chief,” said Peterson. “This appointment is a testament to NYCBS’ unwavering commitment to fostering diversity and developing leadership talent. I am excited to align our business development efforts with our strategic direction and execution, and to contribute to the continued growth and success of the company.” 

For more information, please visit nycancer.com.